LEMAITRE VASCULAR, INC. Amortization of Debt Issuance Costs
LEMAITRE VASCULAR, INC. (LMAT) reported Amortization of Debt Issuance Costs of $446.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $224.00K, a 1.36% increase year-over-year.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for the quarter ending 2026-03-31 was $222.00K, a 4.72% increase year-over-year.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $220.00K, a 254.84% increase year-over-year.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $220.00K.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for fiscal 2025 was $873.00K, a 1308.06% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for fiscal 2024 was $62.00K.
- LEMAITRE VASCULAR, INC. amortization of debt issuance costs for fiscal 2023 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $446.00K 10-Q · filed 2026-08-05 | $666.00K derived: sum of 3 quarters · filed 2026-08-05 | $886.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $222.00K 10-Q · filed 2026-05-06 | $442.00K derived: sum of 2 quarters · filed 2026-05-06 | $662.00K derived: sum of 3 quarters · filed 2026-05-06 | $883.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $440.00K derived: sum of 2 quarters · filed 2026-02-26 | $661.00K derived: sum of 3 quarters · filed 2026-08-05 | $873.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $441.00K derived: sum of 2 quarters · filed 2026-08-05 | $653.00K 10-Q · filed 2025-11-07 | $715.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $433.00K 10-Q · filed 2026-08-05 | $495.00K derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-03-31 | $212.00K 10-Q · filed 2026-05-06 | $274.00K derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $62.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |